日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of myosin inhibitors for symptomatic hypertrophic cardiomyopathy: systematic review and meta-analysis

肌球蛋白抑制剂治疗症状性肥厚型心肌病的疗效和安全性：系统评价和荟萃分析

期刊:
影响因子:
doi:10.5114/amsad/209038
Hazique, Mohammad; Lohana, Sameer; Kafle, Sunam; Bhinder, Jasgit; Patel, Kunal N; Basit, Jawad; Bahar, Abdul Rasheed; Kvapil, Jared; Alraies, M Chadi
心血管
心肌病
发表日期：2025
文献求助 收藏

A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors

一项针对局部晚期或转移性实体瘤患者的 adavosertib（一种选择性 Wee1 抑制剂）的 Ib 期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-023-01371-6
Falchook, Gerald S; Sachdev, Jasgit; Imedio, Esteban Rodrigo; Kumar, Sanjeev; Mugundu, Ganesh M; Jenkins, Suzanne; Chmielecki, Juliann; Jones, Suzanne; Spigel, David R; Johnson, Melissa
发表日期：2023
文献求助 收藏

IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin-paclitaxel, with or without bevacizumab in patients with advanced cancer

IOLite：一项针对晚期癌症患者的1b期临床试验，研究多斯利单抗联合尼拉帕尼、卡铂-紫杉醇，加或不加贝伐珠单抗的双药/三药联合方案。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003924
Yap, Timothy A; Bessudo, Alberto; Hamilton, Erika; Sachdev, Jasgit; Patel, Manish R; Rodon, Jordi; Evilevitch, Lena; Duncan, Meghan; Guo, Wei; Kumar, Sujatha; Lu, Sharon; Dezube, Bruce J; Gabrail, Nashat
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors

克服紫杉烷耐药性：选择性糖皮质激素受体调节剂 Relacorilant 与白蛋白结合型紫杉醇在实体肿瘤中的临床前和 1 期研究

期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-21-4363
Pamela N Munster #, Andrew E Greenstein #, Gini F Fleming, Erkut Borazanci, Manish R Sharma, Joseph M Custodio, Iulia Cristina Tudor, Hristina I Pashova, Stacie Peacock Shepherd, Andreas Grauer, Jasgit C Sachdev
肿瘤
发表日期：2022
文献求助 收藏

Multiple Gastrointestinal Symptoms Are Associated With Chemotherapy-Induced Nausea in Patients With Breast Cancer

乳腺癌患者化疗引起的恶心常伴有多种胃肠道症状

期刊:Cancer Nursing
影响因子:2.5
doi:10.1097/NCC.0000000000000976
Singh, Komal P; Kober, Kord M; Ernst, Brenda; Sachdev, Jasgit; Brewer, Melanie; Zhu, Qiyun; Gu, Haiwei; Melisko, Michele; Paul, Steven M; Cooper, Bruce A; Hammer, Marilyn; Conley, Yvette P; Levine, Jon D; Miaskowski, Christine
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial

多斯塔利单抗（一种抗PD-1药物）在晚期实体瘤患者中的安全性、抗肿瘤活性和药代动力学：一项剂量递增的1期试验

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-021-04358-3
Patnaik, Amita; Weiss, Glen J; Rasco, Drew W; Blaydorn, Lisa; Mirabella, Amy; Beeram, Murali; Guo, Wei; Lu, Sharon; Danaee, Hadi; McEachern, Kristen; Im, Ellie; Sachdev, Jasgit C
肿瘤
肿瘤免疫
PD-1
发表日期：2022
文献求助 收藏

Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial

Capivasertib 对 AKT1 E17K 突变肿瘤患者的疗效：NCI-MATCH 子方案 EAY131-Y 非随机试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2020.6741
Kalinsky, Kevin; Hong, Fangxin; McCourt, Carolyn K; Sachdev, Jasgit C; Mitchell, Edith P; Zwiebel, James A; Doyle, L Austin; McShane, Lisa M; Li, Shuli; Gray, Robert J; Rubinstein, Larry V; Patton, David; Williams, Paul M; Hamilton, Stanley R; Conley, Barbara A; O'Dwyer, Peter J; Harris, Lyndsay N; Arteaga, Carlos L; Chen, Alice P; Flaherty, Keith T
AKT1
肿瘤
AKT
肿瘤免疫
发表日期：2021
文献求助 收藏

First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors

PF-06647020（Cofetuzumab Pelidotin）是一种靶向蛋白酪氨酸激酶7的抗体药物偶联物，在晚期实体瘤中的首次人体研究

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-3757
Maitland, Michael L; Sachdev, Jasgit C; Sharma, Manish R; Moreno, Victor; Boni, Valentina; Kummar, Shivaani; Stringer-Reasor, Erica; Lakhani, Nehal; Moreau, Allison R; Xuan, Dawei; Li, Ray; Powell, Eric L; Jackson-Fisher, Amy; Bowers, Michelle; Alekar, Shilpa; Xin, Xiaohua; Tolcher, Anthony W; Calvo, Emiliano
信号转导
Human
发表日期：2021
文献求助 收藏

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

脂质体伊立替康治疗转移性乳腺癌患者的 I 期研究：扩展阶段的研究结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-020-05995-7
Sachdev, Jasgit C; Munster, Pamela; Northfelt, Donald W; Han, Hyo Sook; Ma, Cynthia; Maxwell, Fiona; Wang, Tiffany; Belanger, Bruce; Zhang, Bin; Moore, Yan; Thiagalingam, Arunthathi; Anders, Carey
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

MRX34（一种脂质体 miR-34a 模拟物）在晚期实体瘤患者中的 1 期研究

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-020-0802-1
Hong, David S; Kang, Yoon-Koo; Borad, Mitesh; Sachdev, Jasgit; Ejadi, Samuel; Lim, Ho Yeong; Brenner, Andrew J; Park, Keunchil; Lee, Jae-Lyun; Kim, Tae-You; Shin, Sangjoon; Becerra, Carlos R; Falchook, Gerald; Stoudemire, Jay; Martin, Desiree; Kelnar, Kevin; Peltier, Heidi; Bonato, Vinicius; Bader, Andreas G; Smith, Susan; Kim, Sinil; O'Neill, Vincent; Beg, Muhammad S
发表日期：2020
文献求助 收藏